Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+10.79%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$10.9B
AUM Growth
+$2.13B
(+24%)
Cap. Flow
+$1.36B
Cap. Flow
% of AUM
12.47%
Top 10 Holdings %
Top 10 Hldgs %
22.74%
Holding
1,019
New
13
Increased
856
Reduced
87
Closed
15
Top Buys
| 1 |
Microsoft
MSFT
|
$63.7M |
| 2 |
Amazon
AMZN
|
$48.9M |
| 3 |
Amgen
AMGN
|
$47.1M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$40.3M |
| 5 |
Honeywell
HON
|
$30.9M |
Top Sells
| 1 |
Vanguard S&P 500 ETF
VOO
|
$29.9M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
$14.6M |
| 3 |
CME Group
CME
|
$9.44M |
| 4 |
Qualcomm
QCOM
|
$8.17M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$6.74M |
Sector Composition
| 1 | Technology | 23% |
| 2 | Healthcare | 12.99% |
| 3 | Consumer Discretionary | 12.21% |
| 4 | Financials | 10.67% |
| 5 | Communication Services | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Under Armour
UAA
$2.26B
| $192K | ﹤0.01% |
17,133
+4,151
| +32% | +$46.5K |
|
|
NPTN
902
DELISTED
NEOPHOTONICS CORP
NPTN
| $191K | ﹤0.01% |
31,383
+1,729
| +6% | +$10.5K |
|
|
GOOD
903
Gladstone Commercial Corp
GOOD
$617M
| $187K | ﹤0.01% |
11,101
+1,726
| +18% | +$29.1K |
|
|
SYRS
904
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $183K | ﹤0.01% |
2,070
-6
| -0.3% | -$530 |
|
|
GMRE
905
Global Medical REIT
GMRE
$505M
| $182K | ﹤0.01% |
13,472
+3,009
| +29% | +$40.7K |
|
|
UMH
906
UMH Properties
UMH
$1.28B
| $180K | ﹤0.01% |
13,320
+2,938
| +28% | +$39.7K |
|
907
Iovance Biotherapeutics
IOVA
$796M
| $178K | ﹤0.01% |
5,421
+199
| +4% | +$6.53K |
|
908
HDFC Bank
HDB
$181B
| $175K | ﹤0.01% |
3,510
+396
| +13% | +$19.7K |
|
|
TNAV
909
DELISTED
Telenav Inc.
TNAV
| $175K | ﹤0.01% |
48,628
+12,100
| +33% | +$43.5K |
|
910
Tanger
SKT
$3.89B
| $172K | ﹤0.01% |
28,465
| – | – |
|
|
VRTU
911
DELISTED
Virtusa Corporation
VRTU
| $172K | ﹤0.01% |
3,492
+1,268
| +57% | +$62.5K |
|
|
BLUE
912
DELISTED
bluebird bio
BLUE
| $170K | ﹤0.01% |
243
-10
| -4% | -$7K |
|
|
ALX
913
Alexander's
ALX
$1.18B
| $169K | ﹤0.01% |
688
+141
| +26% | +$34.6K |
|
914
Under Armour Class C
UA
$2.19B
| $169K | ﹤0.01% |
17,186
| – | – |
|
915
Alaunos Therapeutics
TCRT
$4.27M
| $167K | ﹤0.01% |
442
-18
| -4% | -$6.8K |
|
916
Wipro
WIT
$28.6B
| $166K | ﹤0.01% |
70,616
+8,550
| +14% | +$20.1K |
|
|
CLLS
917
Cellectis
CLLS
$264M
| $163K | ﹤0.01% |
8,835
-203
| -2% | -$3.75K |
|
|
TECX
918
Tectonic Therapeutic, Inc. Common Stock
TECX
$323M
| $162K | ﹤0.01% |
1,035
| – | – |
|
919
Camtek
CAMT
$3.57B
| $160K | ﹤0.01% |
10,409
+687
| +7% | +$10.6K |
|
|
INN
920
Summit Hotel Properties
INN
$617M
| $160K | ﹤0.01% |
30,817
| – | – |
|
921
Sangamo Therapeutics
SGMO
$160M
| $159K | ﹤0.01% |
16,863
-826
| -5% | -$7.79K |
|
922
CONMED
CNMD
$1.69B
| $158K | ﹤0.01% |
2,007
-578
| -22% | -$45.5K |
|
923
Inovio Pharmaceuticals
INO
$146M
| $154K | ﹤0.01% |
1,108
+12
| +1% | +$1.67K |
|
924
Krystal Biotech
KRYS
$4.33B
| $154K | ﹤0.01% |
3,586
+11
| +0.3% | +$472 |
|
925
Iridium Communications
IRDM
$2.61B
| $153K | ﹤0.01% |
5,978
+243
| +4% | +$6.22K |
|